S
0.080
0.00 (0.00%)
Previous Close | 0.080 |
Open | 0.078 |
Volume | 219,331 |
Avg. Volume (3M) | 246,935 |
Market Cap | 16,540,720 |
Price / Sales | 414.46 |
Price / Book | 31.89 |
52 Weeks Range |
Operating Margin (TTM) | -330.80% |
Diluted EPS (TTM) | -0.020 |
Quarterly Revenue Growth (YOY) | 1,091.40% |
Total Debt/Equity (MRQ) | 15.16% |
Current Ratio (MRQ) | 2.42 |
Operating Cash Flow (TTM) | -2.44 M |
Return on Assets (TTM) | -72.20% |
Return on Equity (TTM) | -383.00% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (AU) | Mixed | Mixed |
Health Information Services (Global) | Mixed | Bearish | |
Stock | SINGHEALTH FPO [SHG] | - | - |
AIStockmoo Score
1.1
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 4.0 |
Average | 1.13 |
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
% Held by Insiders | 38.48% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |